As part of its ongoing commitment to improving access to innovative diabetes technology, Spirit Health has announced a CareSens Air Continuous Glucose Monitor (CGM) giveaway for healthcare professionals in the lead-up to World Diabetes Day on November 14.

A simple breath test could soon be a cheaper and quicker way to diagnose diabetes and pre-diabetes, thanks to a new device.

An innovative point-of-care diagnostics solutions provider has donated more than £40,000 worth of vital diabetes supplies to help people living with the condition in Sierra Leone.

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight.

Levemir® insulin, in both its Penfill® and Flexpen® presentations, is to be discontinued, with an anticipated supply end date of December 2026.

Draft NICE guidelines propose upgrading Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors from second choice to first-choice treatments for type 2 diabetes.

A Medicine Supply Notification has been issued by the Department of Health and Social Care about the discontinuation of Wockhardt’s Hypurin Porcine insulin range in 10ml vials.

The Diabetes Africa UK Forum returns for its third year in 2025, continuing its mission to advance equity in diabetes care for Black populations.

People from Afro-Caribbean and South Asian backgrounds are less likely to be prescribed “life-changing” diabetes technology compared to White individuals, a new study has reported.

Professor Gerry Rayman, GIRFT joint clinical lead for diabetes, will host a webinar on Tuesday 24 September at 1pm to explore the benefits of the newly launched Community and District Nurse Insulin Programme (CADNIP).

On Monday 11 September, healthcare professionals from across the UK are invited to join a free virtual webinar introducing continuous glucose monitoring (CGM) in secondary care settings. The session, running from 6pm to 7:30pm, is open to both RCN members and non-members and will also be recorded for later access on the RCN Diabetes Forum webpage. 

The first ever immunotherapy for type 1 diabetes has now been licensed for use in the UK.

A leading blood glucose testing company has launched a range of products with Well Pharmacy.

An updated version of the ITS insulin safety e-learning module for staff caring for adults with diabetes in hospital has been launched.

New research has identified a growing confidence among UK nurses and midwives in supporting people with diabetes using continuous glucose monitoring (CGM) technologies, but not so much hybrid closed-loop (HCL) systems.

The Spirit Health Foundation is urging supporters to dig deep and donate to its 2025 Ben Nevis fundraising challenge, ‘Reach the Peak’, taking place from Friday 26 to Sunday 28 September 2025.

Hypo Awareness Week is back from the 6 to 12 October 2025, bringing together registered healthcare professionals from across the UK and Ireland to highlight the dangers of hypoglycaemia.

Spirit Health has announced the launch of a new digitally connected support service for people living with diabetes who are switching to the CareSens Air continuous glucose monitor (CGM).

The Rowan Hillson Inpatient Diabetes Award 2025 is now open for entries – offering healthcare teams across the UK the opportunity to showcase their innovative work in inpatient diabetes care.